Editorial
|
| Targeting PINK1 and MQC in brain tumors |
|
https://doi.org/10.18632/oncotarget.1980
|
| 2864-2865 |
Reviews
|
| HGF/METdirected therapeutics in gastroesophageal cancer: a review of clinical and biomarker development |
|
https://doi.org/10.18632/oncotarget.2003
|
| 2866-2880 |
|
| GSK3 as potential target for therapeutic intervention in cancer |
|
https://doi.org/10.18632/oncotarget.2037
|
| 2881-2911 |
Priority Research Papers
|
| A highly recurrent RPS27 5’UTR mutation in melanoma |
|
https://doi.org/10.18632/oncotarget.2048
|
| 2912-2917 |
Research Papers
|
| microRNAs 424 and 503 are mediators of the antiproliferative and antiinvasive action of the thyroid hormone receptor beta |
|
https://doi.org/10.18632/oncotarget.1577
|
| 2918-2933 |
|
| Necrosis targeted combinational theragnostic approach using radioiodinated Sennidin A in rodent tumor models |
|
https://doi.org/10.18632/oncotarget.1728
|
| 2934-2946 |
|
| Dual Aurora A and JAK2 kinase blockade effectively suppresses malignant transformation |
|
https://doi.org/10.18632/oncotarget.1615
|
| 2947-2961 |
|
| Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production |
|
https://doi.org/10.18632/oncotarget.1561
|
| 2962-2973 |
|
| MicroRNA175p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression |
|
https://doi.org/10.18632/oncotarget.1614
|
| 2974-2987 |
|
| Caspase8mediated PAR4 cleavage is required for TNFαinduced apoptosis |
|
https://doi.org/10.18632/oncotarget.1634
|
| 2988-2998 |
|
| WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear βCatenin depend on active PI3K signaling |
|
https://doi.org/10.18632/oncotarget.1626
|
| 2999-3011 |
|
| Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing |
|
https://doi.org/10.18632/oncotarget.1687
|
| 3012-3022 |
|
| Linking offtarget kinase pharmacology to the differential cellular effects observed among PARP inhibitors |
|
https://doi.org/10.18632/oncotarget.1814
|
| 3023-3028 |
|
| Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway |
|
https://doi.org/10.18632/oncotarget.1799
|
| 3029-3038 |
|
| Targeting of multiple myelomarelated angiogenesis by miR199a5p mimics: in vitro and in vivo antitumor activity |
|
https://doi.org/10.18632/oncotarget.1747
|
| 3039-3054 |
|
| 17βestradiol regulates giant vesicle formation via estrogen receptoralpha in human breast cancer cells |
|
https://doi.org/10.18632/oncotarget.1824
|
| 3055-3065 |
|
| Endothelial Deltalike 4 DLL4 promotes renal cell carcinoma hematogenous metastasis |
|
https://doi.org/10.18632/oncotarget.1827
|
| 3066-3075 |
|
| Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients |
|
https://doi.org/10.18632/oncotarget.1832
|
| 3076-3087 |
|
| Targeting the anaphasepromoting complex/cyclosome APC/C bromodomain containing 7 BRD7 pathway for human osteosarcoma |
|
https://doi.org/10.18632/oncotarget.1816
|
| 3088-3100 |
|
| Exogenously delivered heat shock protein 70 displaces its endogenous analogue and sensitizes cancer cells to lymphocytesmediated cytotoxicity |
|
https://doi.org/10.18632/oncotarget.1820
|
| 3101-3114 |
|
| The role of DNA damage and repair in decitabinemediated apoptosis in multiple myeloma |
|
https://doi.org/10.18632/oncotarget.1821
|
| 3115-3129 |
|
| Pololike kinase 1 regulates the stability of the mitotic centromereassociated kinesin in mitosis |
|
https://doi.org/10.18632/oncotarget.1861
|
| 3130-3144 |
|
| Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.1865
|
| 3145-3158 |
|
| Immunoglobulin free light chains are biomarkers of poor prognosis in basallike breast cancer and are potential targets in tumorassociated inflammation |
|
https://doi.org/10.18632/oncotarget.1868
|
| 3159-3167 |
|
| Therapeutic Targeting of cMyc in TCell Acute Lymphoblastic Leukemia TALL |
|
https://doi.org/10.18632/oncotarget.1873
|
| 3168-3172 |
|
| Methylation of CpG sites in RNF180 DNA promoter prediction poor survival of gastric cancer |
|
https://doi.org/10.18632/oncotarget.1888
|
| 3173-3183 |
|
| SIAH2 antagonizes TYK2STAT3 signaling in lung carcinoma cells |
|
https://doi.org/10.18632/oncotarget.1899
|
| 3184-3196 |
|
| Prooncogenic function of HIP55/Drebrinlike DBNL through Ser269/Thr291phosphosensor motifs |
|
https://doi.org/10.18632/oncotarget.1900
|
| 3197-3209 |
|
| Tumor cell apoptosis mediated by cytoplasmic ING1 is associated with improved survival in oral squamous cell carcinoma patients |
|
https://doi.org/10.18632/oncotarget.1907
|
| 3210-3219 |
|
| RAGE mediates S100A4induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis |
|
https://doi.org/10.18632/oncotarget.1908
|
| 3220-3233 |
|
| HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels |
|
https://doi.org/10.18632/oncotarget.1914
|
| 3234-3245 |
|
| The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer |
|
https://doi.org/10.18632/oncotarget.1922
|
| 3246-3260 |
|
| Rad51 supports triple negative breast cancer metastasis |
|
https://doi.org/10.18632/oncotarget.1923
|
| 3261-3272 |
|
| Targeting human apurinic/apyrimidinic endonuclease 1 APE1 in phosphatase and tensin homolog PTEN deficient melanoma cells for personalized therapy |
|
https://doi.org/10.18632/oncotarget.1926
|
| 3273-3286 |
|
| Transmembrane voltage potential of somatic cells controls oncogenemediated tumorigenesis at longrange |
|
https://doi.org/10.18632/oncotarget.1935
|
| 3287-3306 |
|
| Negative regulation of DAB2IP by Akt and SCFFbw7 pathways |
|
https://doi.org/10.18632/oncotarget.1939
|
| 3307-3315 |
|
| The silencing of the SWI/SNF subunit and anticancer gene BRM in Rhabdoid tumors |
|
https://doi.org/10.18632/oncotarget.1945
|
| 3316-3332 |
|
| HDAC 1/4mediated silencing of microRNA200b promotes chemoresistance in human lung adenocarcinoma cells |
|
https://doi.org/10.18632/oncotarget.1948
|
| 3333-3349 |
|
| Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a noninvasive biomarker using urine |
|
https://doi.org/10.18632/oncotarget.1949
|
| 3350-3361 |
|
| Combination of PIM and JAK2 inhibitors synergistically suppresses cell proliferation and overcomes drug resistance of myeloproliferative neoplasms |
|
https://doi.org/10.18632/oncotarget.1951
|
| 3362-3374 |
|
| Phosphorylation of ribosomal protein S6 confers PARP inhibitor resistance in BRCA1deficient cancers |
|
https://doi.org/10.18632/oncotarget.1952
|
| 3375-3385 |
|
| Upregulation of neogenin1 increases cell proliferation and motility in gastric cancer |
|
https://doi.org/10.18632/oncotarget.1960
|
| 3386-3398 |
|
| Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma |
|
https://doi.org/10.18632/oncotarget.1975
|
| 3399-3407 |
|
| ROSmediated EB1 phosphorylation through Akt/GSK3β pathway: implication in cancer cell response to microtubuletargeting agents |
|
https://doi.org/10.18632/oncotarget.1982
|
| 3408-3423 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
